Table 1 Baseline demographic and clinical characteristics
Variables | Value |
|---|---|
Age, (Mean ± SD) (years) | 37.88 ± 9.2 |
Gender, (n, %) | Â |
 Male | 51 (26.3%) |
 Female | 143 (73.7%) |
Marital state, (n, %) | Â |
 Single | 51 (26.3%) |
 Married | 134 (69.1%) |
 Divorced | 9 (4.6%) |
Education, (n, %) | Â |
 Elementary | 5 (2.6%) |
 Cycle | 20 (10.3%) |
 Diploma | 76 (39.2%) |
 Bachelor | 70 (36.1%) |
 Upper than bachelor | 23 (11.9%) |
Job state, (n, %) | Â |
 Employed | 93 (47.9%) |
 Unemployed | 101 (52.1%) |
Disease duration (Mean ± SD) (years) | 8.98 ± 5.68 |
Treatment duration (Mean ± SD) (years) | 3.44 ± 3.11 |
EDSS score, (Mean ± SD) | 1.23 ± 1.49 |
Treatment, (n, %) | Â |
 IFN-B1a | 33 (17%) |
 IFN-B1b | 8 (4.1%) |
 Rituximab | 68 (35.1%) |
 Ocrelizumab | 4 (2.1%) |
 Glatiramer acetate | 4 (2.1%) |
 Fingolimod | 13 (6.7%) |
 Teriflunomid | 32 (16.5%) |
 DMF | 18 (9.3%) |
 Fampridine | 4 (2.1%) |
 No treatment | 10 (5.2%) |